Fused piperidinyl bicyclic and related compounds as modulators of C5A receptor
US11149009B2 · kind B2 · utility
3Cited by
1References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 7, 2020 |
| Grant date | Oct 19, 2021 |
| Priority date | — |
| Expiry date | Feb 7, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to fused piperidinyl bicyclic, meta-substituted piperidinyl and their related compounds that modulate activities of mammalian C5a receptor by directly binding to the C5a receptor. The invention also relates to pharmaceutical compositions containing such compounds and their use in the treatment of a disease or a disorder involving pathogenic activation of C5a receptors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.